Amneal Pharmaceuticals, Inc..
AMRX.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Amneal Pharmaceuticals, Inc. is a pharmaceutical company that develops, manufactures, and distributes a diverse portfolio of generic and specialty pharmaceutical products. The company focuses on producing affordable medicines across a broad range of therapeutic areas, including complex generics and ...Show More
Better Health for All
-20
Amneal Pharmaceuticals' core business, which includes launching 39 new generic and injectable products in 2023 and 22 in 2024, and filling 162 million prescriptions in the U.S. in 2024, indicates that a significant majority of its product portfolio delivers substantial health benefits.
1
The company's efforts have resulted in $18.25 billion in patient savings in 2024, demonstrating improved price accessibility.
2
Over 10 years, Amneal has donated 22 million medication doses to Dispensary of Hope, providing free or low-cost access to uninsured and low-income patients approximately 3,000 times daily.
3
This program specifically targets uninsured and low-income populations, reaching 75-85% of vulnerable populations.
4
The company also produces critical injectable medicines and donated Naloxone, which can be considered a response to health crises.
5
However, the company's 2023 ESG report mentions scientific innovation but provides no specific R&D or capital allocation figures for health improvement.
6
While the donation program is significant, it represents a limited equity program with unverified effectiveness relative to the company's overall revenue.
Fair Money & Economic Opportunity
0
Amneal Pharmaceuticals, Inc. is a pharmaceutical company that develops, manufactures, and distributes generic and specialty pharmaceutical products.
1
The ethical value 'Fair Money & Economic Opportunity' is defined as covering activities that lend, insure, move, or store money, and evaluates how financial institutions democratize access to fair financial services. The provided articles discuss drug pricing and related transparency laws, which pertain to healthcare product costs, not financial services or products. As the company's core business and the evidence do not relate to financial services, all KPIs under this value are not applicable, and no relevant data points were found to score them.
Fair Pay & Worker Respect
-40
Amneal Pharmaceuticals' CEO-to-median employee pay ratio is 409:1, with the CEO receiving $5,062,732 and the median employee earning $12,380.
1
The company has incurred three substantiated labor-law violations related to workplace safety in the past three years, specifically in 2022 and 2024, with penalties of $8,439, $6,250, and $8,511 respectively.
2
Employee reviews from one source indicate an overall rating of 4.2/5, while another shows 3.5/5, with mixed feedback on salary, job security, and work satisfaction.
3
Some reviews mention low pay compared to industry standards and concerns about long hours.
4
Fair Trade & Ethical Sourcing
0
No evidence available to assess Amneal Pharmaceuticals, Inc. on Fair Trade & Ethical Sourcing.
Honest & Fair Business
-40
Amneal Pharmaceuticals received an FDA warning letter on August 27, 2025,
1
which falls within the past three years, but no ethics-related fines are reported.
2
The company has an 'Amtegrity Line' hotline available 24/7 for employees and suppliers to report concerns without fear of retaliation,
3
and states it will promptly investigate and take appropriate action.
4
However, there is no explicit evidence of independent investigation processes or specific resolution timeframes.
5
Amneal has a Global Anticorruption Policy that prohibits bribery and illegal inducements,
6
and a Global Supplier Code of Conduct requiring suppliers to have systems to prevent corruption and comply with applicable laws.
7
While an FCPA-compliant policy is in place, the frequency and effectiveness metrics of anti-corruption training are not detailed.
Kind to Animals
-40
The company conducts pre-clinical animal testing.
1
However, no details on the scope or enforcement of its animal testing policy are provided.
2
There is no information on the volume of animals used, the extent of alternative testing methods employed, or any certifications related to cruelty-free products or humane operations.
3
The available articles also lack data on ethical input substitution, supplier audits for animal welfare, cage-free sourcing, wildlife conservation impact, R&D investment in animal-free technologies, animal agriculture ethics, animal-free R&D collaborations, or public policy engagement related to animal welfare.
4
No War, No Weapons
0
Amneal Pharmaceuticals acquired a 65.1% majority interest in AvKARE, a private label generic pharmaceutical provider primarily serving the Department of Defense.
1
As a pharmaceutical company, its products are not considered controversial or banned weapons.
Planet-Friendly Business
-40
The company recorded one hazardous waste violation in 2020 with a penalty of $10,800, and another hazardous waste violation in 2019 with a penalty of $32,400.
1
Other environmental violations include one in 2011 for $25,000 and one in 2007 for $9,000.
2
Respect for Cultures & Communities
0
No evidence available to assess Amneal Pharmaceuticals, Inc. on Respect for Cultures & Communities.
Safe & Smart Tech
-10
Amneal Pharmaceuticals has no documented data breaches or incidents of unauthorized data use.
1
The company conducts baseline cybersecurity training for all new employees, annual mandatory interactive training for all users, frequent awareness emails, targeted training, and remediation after phishing simulation failures.
2
Quarterly scenario-based tabletop exercises are also conducted.
3
Multi-factor authentication is implemented for remote access and certain internal systems.
4
Data loss prevention is used for email traffic containing sensitive information.
5
The company performs vulnerability scanning on internal and external infrastructure, prioritizing critical and high vulnerabilities for swift remediation, with critical vulnerabilities patched within 21-30 days on average.
6
Periodic penetration tests are conducted by a third-party service provider.
7
Amneal states a commitment to complying with all applicable laws and regulations and developed its 2024 Responsible Business Report with reference to GRI and SASB standards, aligning with UN Sustainable Development Goals.
8
Zero Waste & Sustainable Products
-50
Amneal Pharmaceuticals implemented a sustainability-focused Inventory Management Plan, Standard Operating Procedures, and initial Workflow documents.
1
In 2023, the company recycled 66,000 pounds of plastic and cardboard from three Kentucky distribution facilities, saving 562 cubic yards of landfill space.
2
The company has not reported any waste disposal violations in the past three years, with the most recent hazardous waste violation penalty recorded in 2020.
3
However, there is no evidence of specific hazardous waste reduction initiatives. The company has not disclosed specific waste reduction targets or timelines.
4